These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36483266)

  • 1. Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosis.
    Mikolasch TA; George PM; Sahota J; Nancarrow T; Barratt SL; Woodhead FA; Kouranos V; Cope VSA; Creamer AW; Fidan S; Ganeshan B; Hoy L; Mackintosh JA; Shortman R; Duckworth A; Fallon J; Garthwaite H; Heightman M; Adamali HI; Lines S; Win T; Wollerton R; Renzoni EA; Steward M; Wells AU; Gibbons M; Groves AM; Gooptu B; Scotton CJ; Porter JC
    EClinicalMedicine; 2023 Jan; 55():101758. PubMed ID: 36483266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-lymphocyte ratio being associated with mortality risk in patients receiving antifibrotic therapy.
    Takuma S; Suzuki Y; Kono M; Hasegawa H; Hashimoto D; Yokomura K; Mori K; Shimizu M; Inoue Y; Yasui H; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Suda T
    Respir Med; 2024 Mar; 223():107542. PubMed ID: 38331228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Role of NLR, PLR and MHR in Patients With Idiopathic Pulmonary Fibrosis.
    Chen Y; Cai J; Zhang M; Yan X
    Front Immunol; 2022; 13():882217. PubMed ID: 35572564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.
    Maher TM; Oballa E; Simpson JK; Porte J; Habgood A; Fahy WA; Flynn A; Molyneaux PL; Braybrooke R; Divyateja H; Parfrey H; Rassl D; Russell AM; Saini G; Renzoni EA; Duggan AM; Hubbard R; Wells AU; Lukey PT; Marshall RP; Jenkins RG
    Lancet Respir Med; 2017 Dec; 5(12):946-955. PubMed ID: 29150411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study.
    Niwamoto T; Handa T; Murase Y; Nakatsuka Y; Tanizawa K; Taguchi Y; Tomioka H; Tomii K; Kita H; Uyama M; Tsuchiya M; Emura M; Kawamura T; Arai N; Arita M; Uno K; Yoshizawa A; Uozumi R; Yamaguchi I; Matsuda F; Chin K; Hirai T
    Respir Res; 2021 Jun; 22(1):181. PubMed ID: 34158044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum human epididymis protein 4 is associated with disease severity and worse survival in idiopathic pulmonary fibrosis: a cohort study.
    Tian M; Meng K; Gao Y; Zhang J; Xie M; Tian Y; Liu X; Ma M; Cai Y; Wu H; Ding J; Chen J; Cai H
    Ann Transl Med; 2022 Sep; 10(18):992. PubMed ID: 36267722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease: An International Cohort Study.
    Khor YH; Gutman L; Abu Hussein N; Johannson KA; Glaspole IN; Guler SA; Funke-Chambour M; Geiser T; Goh NSL; Ryerson CJ
    Chest; 2021 Sep; 160(3):994-1005. PubMed ID: 33905679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of peripheral neutrophil to lymphocyte ratio and peripheral monocyte levels to predict survival in fibrotic hypersensitivity pneumonitis (fHP): a multicentre retrospective cohort study.
    Barratt SL; Creamer AW; Adamali HI; Duckworth A; Fallon J; Fidan S; Nancarrow T; Wollerton R; Steward M; Gooptu B; Gibbons M; Woodhead FA; Scotton C
    BMJ Open Respir Res; 2021 Nov; 8(1):. PubMed ID: 34794958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing long-term outcomes in fibrotic interstitial lung disease (F-ILD) diagnosed through multidisciplinary discussion (MDD): a prospective cohort study.
    Liao YW; Liu MC; Wu YC; Hsu CY; Huang WN; Chen YH; Fu PK
    Eur J Med Res; 2024 Jan; 29(1):91. PubMed ID: 38291459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    Justet A; Laurent-Bellue A; Thabut G; Dieudonné A; Debray MP; Borie R; Aubier M; Lebtahi R; Crestani B
    Respir Res; 2017 Apr; 18(1):74. PubMed ID: 28449678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary
    Win T; Screaton NJ; Porter JC; Ganeshan B; Maher TM; Fraioli F; Endozo R; Shortman RI; Hurrell L; Holman BF; Thielemans K; Rashidnasab A; Hutton BF; Lukey PT; Flynn A; Ell PJ; Groves AM
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):806-815. PubMed ID: 29335764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone.
    Lacedonia D; Correale M; Tricarico L; Scioscia G; Stornelli SR; Simone F; Casparrini M; Brunetti ND; Foschino Barbaro MP
    Intern Emerg Med; 2022 Apr; 17(3):815-822. PubMed ID: 34787802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-to-Lymphocyte Ratio in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Arai T; Takimoto T; Takeuchi N; Minomo S; Kagawa T; Inoue Y
    J Clin Med; 2023 Nov; 12(23):. PubMed ID: 38068497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary Fibrosis.
    Hozumi H; Kataoka K; Kondoh Y; Isayama T; Okada J; Sugiura K; Mori K; Kono M; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Suda T
    Chest; 2021 Dec; 160(6):2149-2157. PubMed ID: 34252438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in management of idiopathic pulmonary fibrosis: impact on disease severity and mortality.
    Hyldgaard C; Møller J; Bendstrup E
    Eur Clin Respir J; 2020 Aug; 7(1):1807682. PubMed ID: 32944203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases.
    Hirata M; Hara Y; Fujii H; Murohashi K; Saigusa Y; Zhao S; Kobayashi M; Nagasawa R; Tagami Y; Izawa A; Otsu Y; Watanabe K; Horita N; Kobayashi N; Kaneko T
    BMC Pulm Med; 2024 Jan; 24(1):16. PubMed ID: 38183005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Aggregate Index of Systemic Inflammation (AISI): A Novel Prognostic Biomarker in Idiopathic Pulmonary Fibrosis.
    Zinellu A; Collu C; Nasser M; Paliogiannis P; Mellino S; Zinellu E; Traclet J; Ahmad K; Mangoni AA; Carru C; Pirina P; Fois AG; Cottin V
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified GAP model for East-Asian populations with idiopathic pulmonary fibrosis.
    Nishikiori H; Chiba H; Lee SH; Kondoh S; Kamo KI; Nakamura K; Ikeda K; Kuronuma K; Chung MP; Kondoh Y; Homma S; Inase N; Park MS; Takahashi H
    Respir Investig; 2020 Sep; 58(5):395-402. PubMed ID: 32718834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L; Cai K; Wang K; Luo Q
    J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.